Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Open Access
- 31 March 2005
- journal article
- research article
- Published by Elsevier
- Vol. 7 (3) , 239-249
- https://doi.org/10.1016/j.ccr.2005.01.027
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Tolerance to Islet Antigens and Prevention from Diabetes Induced by Limited Apoptosis of Pancreatic β CellsImmunity, 2002
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytomaEuropean Journal of Immunology, 1996
- Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 inductionEndocrinology, 1995
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989